Skip to content

Insmed INSM Common Stock

Common Stock at other companies

Sarepta Therapeutics, Inc. logo
Sarepta Therapeutics, Inc.SRPT
$11K+10.0%
United Therapeutics logo
United TherapeuticsUTHR
$800K0.0%
Solid Biosciences Inc. logo
Solid Biosciences Inc.SLDB
$98K+27.3%
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
$3K+50.0%
Savara logo
SavaraSVRA
$204K+17.9%
ArriVent BioPharma, Inc. logo
ArriVent BioPharma, Inc.AVBP
$5K+25.0%

Other financials

Income statement

See full
Revenue$306.0M+230%
Gross profit$258.5M+261%
Operating income-$153.3M+38.2%
Net income-$163.6M+36.3%
EPS (diluted)-$0.76+46.5%

Balance sheet

See full
Cash & equivalents$582.2M+44.4%
Total debt$580.3M-49.2%
Total equity$704.9M+611%
Total assets$2.1B+15.2%

Cash flow

See full
Operating cash flow-$222.7M+15.0%
CapEx$3.5M-65.4%
Free cash flow-$226.2M+16.9%

Valuation

See full
Market cap$23.11B+17.6%
Enterprise value$23.11B+22.0%
P/S28.2×-21.1×

Profitability

See full
Gross margin81.8%+5.3pp
Operating margin-140.6%-43.9pp
Net margin-144.4%-45.3pp
FCF margin-112.5%-35.3pp

Returns & leverage

See full
Return on equity-294.5%
Debt / equity0.8×-10.7×
Current ratio4.5×-1.4×

Where this comes from

Reported directly by Insmed in its filing.

Tagged under the XBRL concept us-gaap:CommonStockValue.

The official record: Insmed’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Insmed's common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Insmed's common stock?
Insmed (INSM) reported common stock of $2.17M in Q1 2026.
How has Insmed's common stock changed year-over-year?
Insmed's common stock increased by 19.0% year-over-year, from $1.82M to $2.17M.
What is the long-term trend for Insmed's common stock?
Over 5 years (2020 to 2025), Insmed's common stock has grown at a 15.8% compound annual growth rate (CAGR), from $1.03M to $2.14M.
What does common stock mean?
The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).